Personalized Evidence-Based Management of Patent Ductus Arteriosus in Preterm Infants

Personalized Evidence-Based Management of Patent Ductus Arteriosus in Preterm Infants

There is no universal consensus on management of patent ductus arteriosus (PDA) in preterm infants and it varies significantly worldwide, even among the clinicians within units. The decision to treat requires a thorough understanding of the clinical status of the patient, clinical evaluation of PDA,...

Full description

Bibliographic Details
Main Authors: Belinda Chan, Yogen Singh
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
patent ductus arteriosus (PDA)
premature infant
preterm infant
medical treatment
indomethacin
ibuprofen
Online Access:https://www.mdpi.com/2308-3425/11/1/7

Similar Items

Similar Items